Neurogene (NGNE) Other Non-Current Assets (2013 - 2026)
Neurogene (NGNE) reported Other Non-Current Assets of $300000.0 for Q1 2026, little changed on a YoY basis from $300000.0 in Q1 2025, and down 11.5% quarter-over-quarter from $339000.0 in Q4 2025.
Neurogene (NGNE) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Neurogene has reported Other Non-Current Assets for 13 years, with the latest figure at $300000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $300000.0; the trailing twelve-month figure through Mar 2026 stood at $300000.0 (changed 0.0% YoY), and the FY2025 full-year result was $339000.0, down 65.23% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $300000.0, down from $339000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $2.0 million in Q2 2022, with the low at $300000.0 in Q3 2024.
- Historically, Other Non-Current Assets has averaged $814250.0 across 5 years, with a median of $636000.0 in 2023.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets slumped 73.81% — and 2024, when it soared 50.09%.
- Neurogene's Other Non-Current Assets stood at $1.9 million in 2022, then tumbled by 60.04% to $764000.0 in 2023, then advanced by 27.62% to $975000.0 in 2024, then sank by 65.23% to $339000.0 in 2025, then slipped by 11.5% to $300000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $300000.0 (Q1 2026), $339000.0 (Q4 2025), and $339000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Neurogene | 216.17 Mn | 216.17 Mn | - | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 339,000.00 |
| Sep 30, 2025 | 339,000.00 |
| Jun 30, 2025 | 339,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 975,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 794,000.00 |
| Mar 31, 2024 | 743,000.00 |
| Dec 31, 2023 | 764,000.00 |
| Sep 30, 2023 | 524,000.00 |
| Jun 30, 2023 | 529,000.00 |
| Mar 31, 2023 | 905,000.00 |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 1.93 Mn |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 1.93 Mn |
| Mar 31, 2021 | 1.92 Mn |